1. Tingaud-Sequeira, Angèle, Trimouille, Aurélien, Salaria, Manju, Lacombe, Didier, Rooryck, Caroline. 2021. A recurrent missense variant in EYA3 gene is associated with oculo-auriculo-vertebral spectrum. In Human genetics, 140, 933-944. doi:10.1007/s00439-021-02255-6. https://pubmed.ncbi.nlm.nih.gov/33475861/
2. Wiedner, Hannah J, Blue, R Eric, Sadovsky, Matheus, Herring, Laura E, Giudice, Jimena. 2023. RBFOX2 regulated EYA3 isoforms partner with SIX4 or ZBTB1 to control transcription during myogenesis. In iScience, 26, 108258. doi:10.1016/j.isci.2023.108258. https://pubmed.ncbi.nlm.nih.gov/38026174/
3. Wang, Yuhua, Pandey, Ram Naresh, Roychoudhury, Kaushik, Pressey, Joseph G, Hegde, Rashmi S. 2021. Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis. In Molecular cancer therapeutics, 20, 803-815. doi:10.1158/1535-7163.MCT-20-0749. https://pubmed.ncbi.nlm.nih.gov/33649104/
4. Vartuli, Rebecca L, Zhou, Hengbo, Zhang, Lingdi, Zhao, Rui, Ford, Heide L. 2018. Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation. In The Journal of clinical investigation, 128, 2535-2550. doi:10.1172/JCI96784. https://pubmed.ncbi.nlm.nih.gov/29757193/